Gangula
Gidda Reddy Gangula, Sunnyvale, CA US
Patent application number | Description | Published |
---|---|---|
20130138911 | MEMORY CONTROLLER WITH RECONFIGURABLE HARDWARE - Memory controller concepts are disclosed in which hardware resources of a memory controller can be re-used or re-configured to accommodate various different memory configurations. The memory configuration may be stored in mode register bits ( | 05-30-2013 |
Pandu R.r. Gangula, Houston, TX US
Patent application number | Description | Published |
---|---|---|
20080207579 | Uses of tetrahydrobiopterin and derivatives thereof - The present invention discloses that diabetic rats showed a reduction in nitrergic relaxation of the gastric, impaired nNOS dimerization, decreased BH4 and GTPCH1 levels and thus, are more susceptible to develop diabetic gastroparesis. The use of tetrahydrobiopterin and its derivatives and sex steroid hormones as disclosed herein provides a novel strategy for therapeutic intervention of diabetic gastroparesis and any other gut-related diseases. Additionally, the present invention also discloses methods to determine risk of developing gastroparesis in an individual that are drawn to detecting variations in the activity and levels of GCH gene and in gene encoding sex steroid hormone receptor. | 08-28-2008 |
Pandu R.r. Gangula, Nolensville, TN US
Patent application number | Description | Published |
---|---|---|
20110098306 | Uses of tetrahydrobiopterin, sepiapterin and derivatives thereof - The present invention discloses that diabetic rats showed a reduction in nitrergic relaxation of the gastric, impaired nNOS dimerization, decreased BH4 and GTPCH1 levels and thus, are more susceptible to develop diabetic gastroparesis. The use of tetrahydrobiopterin and its derivatives and sex steroid hormones as disclosed herein provides a novel strategy for therapeutic intervention of diabetic gastroparesis and any other gut-related diseases. Additionally, the present invention also discloses methods to determine risk of developing gastroparesis in an individual that are drawn to detecting variations in the activity and levels of GCH gene and in gene encoding sex steroid hormone receptor. | 04-28-2011 |
20140249152 | TREATMENT FOR GASTROPARESIS USING SEPIAPTERIN - The present invention discloses that diabetic rats showed a reduction in nitrergic relaxation of the gastric, impaired nNOS dimerization, decreased BH4 and GTPCH1 levels and thus, are more susceptible to develop diabetic gastroparesis. The use of tetrahydrobiopterin and its derivatives and sex steroid hormones as disclosed herein provides a novel strategy for therapeutic intervention of diabetic gastroparesis and any other gut-related diseases. Additionally, the present invention also discloses methods to determine risk of developing gastroparesis in an individual that are drawn to detecting variations in the activity and levels of GCH gene and in gene encoding sex steroid hormone receptor. | 09-04-2014 |
Srinivas Gangula, Karimnagar IN
Patent application number | Description | Published |
---|---|---|
20120046457 | PREPARATION OF DECITABINE - The present application relates to processes for the preparation and purification of decitabine structurally represented by formula (I): | 02-23-2012 |
20140243412 | PROCESS FOR PREPARATION OF PREGABALIN - Aspects of the present invention relate to improved process for preparation of (R)(−)-3-(carbamoylmethyl)-5-methylhexanoic acid (R-CMHA) of the formula (II) or its pharmaceutically acceptable salts in the presence of a lewis acid, process for preparation of pregabalin using R-CMHA of the formula (II) or its pharmaceutically acceptable salts prepared according to the present invention and process for preparation of pregabalin with low amount of undesired impurity. | 08-28-2014 |
Srinivas Gangula, Karimnagar District IN
Patent application number | Description | Published |
---|---|---|
20080214535 | Amorphous Aprepitant Coprecipitates - A coprecipitate comprising amorphous aprepitant and a pharmaceutically acceptable carrier is prepared by rapidly removing solvent from a solution containing aprepitant and the carrier. | 09-04-2008 |
Srinivas Gangula, City Hyderabad IN
Patent application number | Description | Published |
---|---|---|
20090018351 | PREPARATION OF ESCITALOPRAM - The present invention relates to a process for preparing enantiomerically enriched citalopram via methylating enantiomerically enriched didesmethylcitalopram, which is prepared by directly resolving racemic didesmethylcitalopram using a chiral acid. | 01-15-2009 |
Srinivas Gangula, Hyderabad IN
Patent application number | Description | Published |
---|---|---|
20090048336 | ESCITALOPRAM OXALATE POWDERS - Escitalopram oxalate powders having definite particle size distribution parameters, processes for preparing the powders, and solid pharmaceutical formulations containing the powders. | 02-19-2009 |
20100298327 | APREPITANT POLYMORPH MIXTURES - Intimate mixtures of aprepitant crystalline Form I and crystalline Form II, having specific Hweight ratios of the forms. | 11-25-2010 |
20110028518 | DEXLANSOPRAZOLE PROCESS AND POLYMORPHS - Processes for the preparation of dexlansoprazole, an amorphous form of dexlansoprazole, a solid dispersion of amorphous dexlansoprazole and a pharmaceutically acceptable carrier, and processes for their preparation. Also provided are crystalline compounds 2-[(R)-[(4-chloro-3-methyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole and 2-[(R)-[(4-nitro-3-methyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole, and methods for their preparation. | 02-03-2011 |
20110094321 | PREPARATION OF APREPITANT - A process for preparing aprepitant. | 04-28-2011 |